Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-03-27 to 2024-03-28
Current total value of award: $3303.87
Description: 4564095573!QUILLIVANT XR 25 MG/5 ML SUSP 120ML